---
title: "ROS induction targets persister cancer cells with low metabolic activity in NRAS-mutated melanoma"
date: 2023-04-01
publishDate: 2023-04-01
authors: 
- Ossia M. Eichhoff
- Corinne I. Stoffel
- Jan Käsler
- Luzia Briker
- Patrick Turko
- Gergely Karsai
- Nina Zila
- Verena Paulitschke
- Phil F. Cheng
- Alexander Leitner
- Andrea Bileck
- Nicola Zamboni
- Anja Irmisch
- Zsolt Balazs
- Aizhan Tastanova
- Susana Pascoal
- Pál Johansen
- Rebekka Wegmann
- Julien Mena
- Alaa Othman
- Vasanthi S. Viswanathan
- Judith Wenzina
- Andrea Aloia
- Annalisa Saltari
- Andreas Dzung
- Stuart L. Schreiber
- Thorsten Hornemann
- Martin Distel
- Berend Snijder
- Reinhard Dummer
- Mitchell P. Levesque
publication_types: ["2"]
abstract: "This study identifies a metabolic vulnerability in NRAS-mutated melanoma cells that can be targeted using ROS inducers in combination with MEK inhibitors. Drug-resistant melanoma cells with elevated ROS levels are shown to be highly sensitive to this treatment strategy, offering a potential approach to overcome resistance."
featured: false
projects: [nrased-melanoma, ros-induction]
summary: "This study explores a new therapeutic approach for NRAS-mutated melanomas, targeting drug-resistant cells through ROS induction and metabolic vulnerabilities."
tags:
- Cancer Research
- ROS Induction
- Metabolic Reprogramming
publication: "*Cancer Research*"
doi: "https://doi.org/10.1158/0008-5472.CAN-22-1826"
---
